KC
FPRX

Kellner Capital’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Kellner Capital’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-226,876
Closed -$8.55M – 41
2021
Q1 		$8.55M Buy
+226,876
New +$5.66M 3.1% 13

Kellner Capital's FPRX Position: Q2 2021 in Review

Kellner Capital sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 226,876 shares — an estimated $8.55M sold.

Kellner Capital first reported a position in FPRX in Q1 2021 and held it in 1 quarter. The position peaked at $8.55M in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

  • Kellner Capital reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
  • Kellner Capital sold 226,876 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $8.55M.
  • Kellner Capital first reported a position in Five Prime Therapeutics, Inc. in Q1 2021 and held it in 1 quarter.
  • Kellner Capital's Five Prime Therapeutics, Inc. position peaked at $8.55M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on Kellner Capital's 13F filing for Q2 2021, filed 9 Aug 2021.